Correlation Between Arbutus Biopharma and VBI Vaccines
Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and VBI Vaccines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and VBI Vaccines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arbutus Biopharma Corp and VBI Vaccines, you can compare the effects of market volatilities on Arbutus Biopharma and VBI Vaccines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of VBI Vaccines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and VBI Vaccines.
Diversification Opportunities for Arbutus Biopharma and VBI Vaccines
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Arbutus and VBI is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and VBI Vaccines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VBI Vaccines and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with VBI Vaccines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VBI Vaccines has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and VBI Vaccines go up and down completely randomly.
Pair Corralation between Arbutus Biopharma and VBI Vaccines
If you would invest (100.00) in VBI Vaccines on August 28, 2024 and sell it today you would earn a total of 100.00 from holding VBI Vaccines or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Arbutus Biopharma Corp vs. VBI Vaccines
Performance |
| Timeline |
| Arbutus Biopharma Corp |
| VBI Vaccines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Arbutus Biopharma and VBI Vaccines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arbutus Biopharma and VBI Vaccines
The main advantage of trading using opposite Arbutus Biopharma and VBI Vaccines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, VBI Vaccines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will offset losses from the drop in VBI Vaccines' long position.| Arbutus Biopharma vs. ADMA Biologics | Arbutus Biopharma vs. Adaptimmune Therapeutics Plc | Arbutus Biopharma vs. Affimed NV | Arbutus Biopharma vs. Corvus Pharmaceuticals |
| VBI Vaccines vs. Tonix Pharmaceuticals Holding | VBI Vaccines vs. Jaguar Animal Health | VBI Vaccines vs. Vaxart Inc | VBI Vaccines vs. Allogene Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |